---
title: "Capital has been increasing positions for 3 consecutive days, with the value ETF E Fund (159263) receiving a net subscription of 11 million shares during the session."
type: "Topics"
locale: "zh-HK"
url: "https://longbridge.com/zh-HK/topics/39715363.md"
description: "On April 2nd, Baidu Health held an AI new product launch conference, introducing the AI professional intelligent assistant "Youyi Assistant" for doctors. According to the introduction, Youyi Assistant is the first doctor task-oriented AI assistant in China built on the Claw framework. Unlike general AI assistants, it adopts a dual-engine mode of "retrieval + task", which can achieve both conventional "single dialogue" and automatically "execute tasks". Zhongtai Securities stated..."
datetime: "2026-04-03T03:15:43.000Z"
locales:
  - [en](https://longbridge.com/en/topics/39715363.md)
  - [zh-CN](https://longbridge.com/zh-CN/topics/39715363.md)
  - [zh-HK](https://longbridge.com/zh-HK/topics/39715363.md)
author: "[同壁财经](https://longbridge.com/zh-HK/profiles/26505347.md)"
---

> 支持的語言: [English](https://longbridge.com/en/topics/39715363.md) | [简体中文](https://longbridge.com/zh-CN/topics/39715363.md)


# Capital has been increasing positions for 3 consecutive days, with the value ETF E Fund (159263) receiving a net subscription of 11 million shares during the session.

On April 2nd, Baidu Health held an AI new product launch event, introducing the AI professional intelligent assistant "Youyi Assistant" for doctors. According to reports, Youyi Assistant is the first doctor task-oriented AI assistant in China built on the Claw framework. Different from general-purpose AI assistants, it adopts a dual-engine mode of "retrieval + task," capable of both conventional "single dialogues" and automatic "task execution."

Zhongtai Securities stated that with policy support, breakthroughs and rising popularity in general AI technology, and the gradual improvement of commercialization paths for pathological auxiliary diagnosis, the AI medical sector is worth watching. In terms of AI drug development, AI runs through the entire chain of solving the "inverse Moore's Law" problem, aiming to improve drug R&D efficiency and reduce drug R&D failure rates.

The Huaxia Hong Kong Stock Connect Healthcare ETF (520510) tracks the Hong Kong Stock Connect Healthcare Theme Index, holding leading companies in various sub-sectors such as Alibaba Health, JD Health, and XtalPi. With an AI healthcare weighting exceeding 20%, it is expected to benefit from anti-involution, innovative drug globalization, and the AI technology revolution.

### 相關股票

- [ALI HEALTH (00241.HK)](https://longbridge.com/zh-HK/quote/00241.HK.md)
- [JD HEALTH (06618.HK)](https://longbridge.com/zh-HK/quote/06618.HK.md)
- [JD HEALTH-R (86618.HK)](https://longbridge.com/zh-HK/quote/86618.HK.md)